Spontaneous intracranial hemorrhage as an initial manifestation of primary Sjögren’s syndrome: a case report

[1] Plesivcnik Novljan M(2004)Incidence of primary Sjogren’s syndrome in Slovenia Ann Rheum Dis 63 874-876

[2] Rozman B(2011)Incidence and mortality of treated primary Sjogren’s syndrome in Taiwan: a population-based study J Rheumatol 38 706-708

[3] Hocevar A(2007)Clinical significance of autoantibodies recognizing Sjögren’s syndrome A (SS-A), SSB, calpastatin and alpha-fodrin in primary Sjögren’s syndrome Clin Exp Immunol 148 281-287

[4] Grmek M(2010)Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable clinical, serological characteristics and outcomes in a large cohort of Italian patients Rheumatology (Oxford) 49 1540-1549

[5] Kveder T(2004)Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients Medicine (Baltimore) 83 280-291

[6] Tomsic M(2005)The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy Brain 128 2518-2534

[7] Weng MY(2012)Central and peripheral neurological complications of primary Sjögren’s syndrome Presse Med 41 e485-e493

[8] Huang YT(2012)Moyamoya Disease Presenting as Thalamic Hemorrhage in A Patient With Neuromyelitis Optica and Sjögren’s Syndrome J Stroke Cerebrovasc Dis 21 619. e7-9

[9] Liu MF(2012)Syringomyelia and arachnoid cysts associated with spinal arachnoiditis following subarachnoid hemorrhage Neurol Med Chir (Tokyo) 52 686-690

[10] Lu TH(2010)Recurrence of subarachnoid hemorrhage due to the rupture of cerebral aneurysms in a patient with Sjögren’s syndrome: case report Neurol Med Chir (Tokyo) 50 658-661

[1] Plesivcnik Novljan M(2004)Incidence of primary Sjogren’s syndrome in Slovenia Ann Rheum Dis 63 874-876

[2] Rozman B(2011)Incidence and mortality of treated primary Sjogren’s syndrome in Taiwan: a population-based study J Rheumatol 38 706-708

[3] Hocevar A(2007)Clinical significance of autoantibodies recognizing Sjögren’s syndrome A (SS-A), SSB, calpastatin and alpha-fodrin in primary Sjögren’s syndrome Clin Exp Immunol 148 281-287

[4] Grmek M(2010)Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable clinical, serological characteristics and outcomes in a large cohort of Italian patients Rheumatology (Oxford) 49 1540-1549

[5] Kveder T(2004)Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients Medicine (Baltimore) 83 280-291

[6] Tomsic M(2005)The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy Brain 128 2518-2534

[7] Weng MY(2012)Central and peripheral neurological complications of primary Sjögren’s syndrome Presse Med 41 e485-e493

[8] Huang YT(2012)Moyamoya Disease Presenting as Thalamic Hemorrhage in A Patient With Neuromyelitis Optica and Sjögren’s Syndrome J Stroke Cerebrovasc Dis 21 619. e7-9

[9] Liu MF(2012)Syringomyelia and arachnoid cysts associated with spinal arachnoiditis following subarachnoid hemorrhage Neurol Med Chir (Tokyo) 52 686-690

[10] Lu TH(2010)Recurrence of subarachnoid hemorrhage due to the rupture of cerebral aneurysms in a patient with Sjögren’s syndrome: case report Neurol Med Chir (Tokyo) 50 658-661